Piperacillin/tazobactam/vancomycinNephrotoxicity

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-024-59190-1
中图分类号
学科分类号
摘要
引用
收藏
页码:296 / 296
相关论文
共 50 条
  • [11] PHARMACOKINETIC CHARACTERISTICS OF PIPERACILLIN TAZOBACTAM
    SORGEL, F
    KINZIG, M
    INTENSIVE CARE MEDICINE, 1994, 20 : S14 - S20
  • [13] Criteria for comparison of the combinations piperacillin/tazobactam and piperacillin/sulbactam
    Heizmann, W. R.
    Derendorf, H.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2005, 19 (02): : 89 - 99
  • [14] Synergistic effect of polyethylenimine plus piperacillin/tazobactam on clinicalPseudomonas aeruginosa isolates resistant to piperacillin/tazobactam
    Giovanni Bonfiglio
    Annals of Microbiology, 2006, 56 : 345 - 348
  • [15] Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam
    Pournaras, Spyros
    Ikonomidis, Alexandros
    Neou, Evangelia
    Kantzanou, Maria
    Maniatis, Antonios N.
    Tsakris, Athanassios
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 757 - 758
  • [16] Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers
    Strenkoski-Nix, LC
    Forrest, A
    Schentag, JJ
    Nix, DE
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (11): : 1063 - 1071
  • [17] Synergistic effect of polyethylenimine plus piperacillin/tazobactam on clinical Pseudomonas aeruginosa isolates resistant to piperacillin/tazobactam
    Bonfiglio, Giovanni
    ANNALS OF MICROBIOLOGY, 2006, 56 (04) : 345 - 348
  • [18] Reevaluating Piperacillin-Tazobactam Mortality
    Darlow, Christopher A.
    Gerada, Alessandro
    Hope, William
    JAMA INTERNAL MEDICINE, 2024, 184 (10) : 1267 - 1268